Bank of Montreal
SCPH

Bank of Montreal’s scPharmaceuticals SCPH Stock Holding History

Bank of Montreal’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-351,806
Closed -$1.54M – 4191
2024
Q2 		$1.54M Buy
+351,806
New +$1.55M ﹤0.01% 1784
2023
Q1 		– Sell
-69,600
Closed -$501K – 4130
2022
Q4 		$501K Buy
+69,600
New +$425K ﹤0.01% 2610
2021
Q2 		– Sell
-261
Closed -$2K – 4739
2021
Q1 		$2K Sell
261
-880
-77% -$6.03K ﹤0.01% 4917
2020
Q4 		$7K Buy
1,141
+814
+249% +$6.37K ﹤0.01% 4726
2020
Q3 		$3K Sell
327
-109
-25% -$852 ﹤0.01% 4591
2020
Q2 		$3K Buy
+436
New +$3.83K ﹤0.01% 4492
2019
Q1 		– Sell
-88
Closed – – 4687
2018
Q4 		$0 Buy
88
+41
+87% +$193 ﹤0.01% 4827
2018
Q3 		$0 Sell
47
-1
-2% -$5 ﹤0.01% 4867
2018
Q2 		$0 Buy
+48
New +$493 ﹤0.01% 4848

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Bank of Montreal's SCPH Position: Q3 2024 in Review

Bank of Montreal sold out of scPharmaceuticals (SCPH) in Q3 2024, closing a stake of 351,806 shares — an estimated $1.54M sold.

Bank of Montreal first reported a position in SCPH in Q2 2018 and held it in 9 quarters. The position peaked at $1.54M in Q2 2024. 95 funds tracked by Wall St. Rank hold SCPH as of Q3 2024.

  • Bank of Montreal reported no remaining scPharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 351,806 scPharmaceuticals shares in Q3 2024, an estimated $1.54M.
  • Bank of Montreal first reported a position in scPharmaceuticals in Q2 2018 and held it in 9 quarters.
  • Bank of Montreal's scPharmaceuticals position peaked at $1.54M in Q2 2024.
  • 95 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.